<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02370056</url>
  </required_header>
  <id_info>
    <org_study_id>CCFJJN4</org_study_id>
    <nct_id>NCT02370056</nct_id>
  </id_info>
  <brief_title>Evaluation of 3D Visualization for Total Colectomy</brief_title>
  <acronym>3Dvs2DforUC</acronym>
  <official_title>Comparative Assessment of Three-dimensional vs. Conventional Laparoscopy in a Total Colectomy Model for Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The anticipated advantages of 3D laparoscopic visualization for the surgeon are greater&#xD;
      accuracy and speed in manual skills, translating to decreased operative time, reduced&#xD;
      learning curve, and superior safety.We aimed to determine the feasibility of the laparoscopic&#xD;
      approach using 3D visualization in the surgical treatment of ulcerative colitis&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Three-dimensional (3D) visualization technology for laparoscopy has been proposed, since the&#xD;
      early 1990's, as a method to facilitate laparoscopic performance. However, early 3D&#xD;
      laparoscopic technology was limited in terms of image quality, so that its use had not been&#xD;
      implemented. The latest technical developments ensure high-definition 3D visualization with&#xD;
      the same quality that current two-dimensional (2D) systems provide.&#xD;
&#xD;
      The anticipated advantages of 3D laparoscopic visualization for the surgeon are greater&#xD;
      accuracy and speed in manual skills, translating to decreased operative time, reduced&#xD;
      learning curve, and superior safety . It was reported that, 3D laparoscopic visualization&#xD;
      offers significant advantages in enhancing laparoscopic performance, even in novice surgeons,&#xD;
      comparing to the 2D systems . We hypothesize that 3D visualization may allow surgeons to&#xD;
      reduce the overall operating time with a rate of 10% with comparable perioperative and&#xD;
      postoperative outcomes. The primary endpoint of this study is to determine the feasibility of&#xD;
      the laparoscopic approach using 3D visualization in the surgical treatment of ulcerative&#xD;
      colitis. Secondary endpoints are to determine whether 3D visualization confers benefits such&#xD;
      as reduced operating time and intra-operative complications with comparable postoperative&#xD;
      outcomes.&#xD;
&#xD;
      Device Description: The EXERA III Universal Platform will be used in this study, in&#xD;
      conjunction with the ENDOEYE FLEX 3D. The ENDOEYE FLEX 3D can also be used in 2D mode, by&#xD;
      utilizing a programmed button on the handle of the scope, or by using the 2D/3D button on the&#xD;
      3D Visualization Unit. The articulating tip of the ENDOEYE FLEX allows for the scope to be&#xD;
      used in both single-site and multi-port procedures, providing critical views and allowing a&#xD;
      bird's eye view so that the scope is out of the way of other instruments (while still&#xD;
      capturing the image at the surgical site). All equipment used in this trial has been cleared&#xD;
      under 510(k) approval by the FDA, and has been on the market in the US since April 2013.&#xD;
&#xD;
      The Olympus HD 3D Laparoscopic Surgical Video System consists of the following components:&#xD;
&#xD;
        -  CV-190 Processor&#xD;
&#xD;
        -  CLV-190 Light Source&#xD;
&#xD;
        -  3DV-190 3D Visualization Unit&#xD;
&#xD;
        -  LMD-2451MT/3G4 Sony 24&quot; 3D Monitor&#xD;
&#xD;
        -  IMH-20 Image Capture System&#xD;
&#xD;
        -  UHI-4 Insufflator&#xD;
&#xD;
        -  K10021611 Cart&#xD;
&#xD;
        -  OL-0015-08 Tall Rollstand&#xD;
&#xD;
        -  LTF-190-10-3D ENDOEYE FLEX 3D Videoscope&#xD;
&#xD;
        -  3D glasses (regular and clip-on styles)&#xD;
&#xD;
      Study Size:Mean operating time for laparoscopic subtotal colectomy for medically refractory&#xD;
      UC was reported longer with a comparison to open surgery in the recently published studies.&#xD;
&#xD;
      Therefore the effort to decrease operating time in laparoscopic colectomy has gained&#xD;
      importance. We assumed that, in order to be able to determine a 10% reduction in mean&#xD;
      operating time, each group should include 27 patients (80% power and 5% significance).&#xD;
&#xD;
      Patients who will undergo laparoscopic total abdominal colectomy (TAC) for UC will be&#xD;
      included in the study. All subjects will be randomized into two groups: 3D laparoscopy, and&#xD;
      2D laparoscopy. Three staff surgeons (EG, HK, FR) at the department of colorectal surgery,&#xD;
      Cleveland Clinic, Ohio will perform the procedures with 2D and 3D laparoscopy. Each surgeon&#xD;
      will perform 9 total colectomies with 3D, and 9 total colectomies with the 2D laparoscopy&#xD;
      system. In total, 54 patients will be included (27 patients for each group).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">May 17, 2019</completion_date>
  <primary_completion_date type="Actual">May 17, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operating Time</measure>
    <time_frame>180 minutes</time_frame>
    <description>total operating time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Complication</measure>
    <time_frame>180 minutes</time_frame>
    <description>Number of Participants with Intraoperative Complications</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>3D Visualization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2D Visualization</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>3-dimensional visualization</intervention_name>
    <description>Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode</description>
    <arm_group_label>3D Visualization</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>2-dimensional visualization</intervention_name>
    <description>Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode</description>
    <arm_group_label>2D Visualization</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indication for surgery must be Ulcerative Colitis&#xD;
&#xD;
          -  Patient age between 18 and 80&#xD;
&#xD;
          -  Elective procedure&#xD;
&#xD;
          -  BMI between 17 and 30&#xD;
&#xD;
          -  Total colectomy with end ileostomy, without proctectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any preoperative diagnosis other than UC&#xD;
&#xD;
          -  Patient age&lt; 18, or &gt;80&#xD;
&#xD;
          -  Emergency surgery&#xD;
&#xD;
          -  Previous gastrointestinal surgery&#xD;
&#xD;
          -  BMI&gt;30&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Presence of any gastrointestinal tract malignancy&#xD;
&#xD;
          -  Segmental colon resections, completion proctectomy, total proctocolectomy, pouch&#xD;
             procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emre Gorgun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 9, 2015</study_first_submitted>
  <study_first_submitted_qc>February 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 24, 2015</study_first_posted>
  <results_first_submitted>November 22, 2020</results_first_submitted>
  <results_first_submitted_qc>November 22, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 17, 2020</results_first_posted>
  <last_update_submitted>April 14, 2021</last_update_submitted>
  <last_update_submitted_qc>April 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Emre Gorgun</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/56/NCT02370056/Prot_SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 9, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/56/NCT02370056/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>3D Visualization</title>
          <description>3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.&#xD;
3-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode</description>
        </group>
        <group group_id="P2">
          <title>2D Visualization</title>
          <description>2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.&#xD;
2-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>3D Visualization</title>
          <description>3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.&#xD;
3-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode</description>
        </group>
        <group group_id="B2">
          <title>2D Visualization</title>
          <description>2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.&#xD;
2-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="27"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="53"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <population>53 subjects total were included in analysis</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.8" spread="15.2"/>
                    <measurement group_id="B2" value="43.2" spread="17.0"/>
                    <measurement group_id="B3" value="40.0" spread="16.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Average BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="27"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="53"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23.0" spread="4.25"/>
                    <measurement group_id="B2" value="23.9" spread="5.17"/>
                    <measurement group_id="B3" value="23.5" spread="4.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Operating Time</title>
        <description>total operating time</description>
        <time_frame>180 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>3D Visualization</title>
            <description>3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.&#xD;
3-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode</description>
          </group>
          <group group_id="O2">
            <title>2D Visualization</title>
            <description>2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.&#xD;
2-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode</description>
          </group>
        </group_list>
        <measure>
          <title>Operating Time</title>
          <description>total operating time</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.3" spread="30.8"/>
                    <measurement group_id="O2" value="82.7" spread="38.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Complication</title>
        <description>Number of Participants with Intraoperative Complications</description>
        <time_frame>180 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>3D Visualization</title>
            <description>3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.&#xD;
3-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode</description>
          </group>
          <group group_id="O2">
            <title>2D Visualization</title>
            <description>2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.&#xD;
2-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode</description>
          </group>
        </group_list>
        <measure>
          <title>Major Complication</title>
          <description>Number of Participants with Intraoperative Complications</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The standard post-operative period of 30 days.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>3D Visualization</title>
          <description>3-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using 3D Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons.Effect of using 3D Laparoscopic Surgical Video System on operative outcomes will be evaluated.&#xD;
3-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 3D mode</description>
        </group>
        <group group_id="E2">
          <title>2D Visualization</title>
          <description>2-dimensional visualization: In this group, total laparoscopic abdominal colectomy will be performed for patients diagnosed with ulcerative colitis by using conventional Laparoscopic Surgical Video System.&#xD;
This group will be consisted of 27 patients, 9 colectomies performed by 3 surgeons and outcomes will be evaluated.&#xD;
2-dimensional visualization: Subjects are receiving Standard of Care Colectomy for Ulcerative Colitis visualized in 2D mode</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Post-operative ileus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="27"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="27"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Portal vein thrombosis/Deep vein thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Surgical Site Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
              <event>
                <sub_title>Readmission</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="27"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="27"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Emre Gorgun</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216 444-1244</phone>
      <email>GORGUNE@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

